Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.
The test enables donor screening laboratories to use PCR-based diagnostic technology to screen donated blood and plasma.
Professional, molecular, and tissue diagnostics sales continued to grow during the first three quarters, while diabetes care sales remained in decline.
In Nature this week: modified CRISPR approach changes single nucleotides, new salmon genome assembly, and more.
Roche's molecular diagnostics business, which makes up 17 percent of its overall diagnostics sales, grew 11 percent, driven by virology testing and sequencing.
The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.
It's the first approved test to feature the firm's proprietary AmpiProbe nucleic acid amplification and detection platform.
In PNAS this week: decreased DOCK4 expression in myelodysplastic syndromes plus anemia, hepatitis A evolution, and more.
A survey of small mammals from around the world uncovered new and known hepatoviruses that are helping to clarify relationships between viral clades.
The hepatitis C virus test has been approved for both the confirmation of active infection as well as for viral load monitoring.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.